Market Access Management & Consulting
Value & Access expertise for pharma and biotech – HTA, pricing, reimbursement, negotiations.
Open to senior corporate roles (contract-based).
"I combine system insight with hands-on implementation – from HTA strategy and evidence planning to payer communication and field enablement. What drives me is turning complexity into access."
Carolin Knorr-Hendreich
Carolin Knorr-Hendreich
Principal Consultant & Market Access Director
With over 20 years of experience in Market Access, I support pharmaceutical and biotech companies in bringing innovation into care – by aligning strategic value with practical implementation.
My expertise covers the full range of value and access challenges:
• National and EU-level HTA processes (incl. JCA/EU HTA)
• Pricing and reimbursement strategy
• AMNOG and §130b negotiations
• Regional contracts and field force enablement
• Cross-functional stakeholder collaboration
• Real-world evidence and managed care
• Launch planning in rare diseases, oncology, cardiology, immunology, CNS and specialty care
My clients include established pharma companies, emerging biotech firms and life science service providers.
I work at the interface of system logic and patient access – with a pragmatic, field-oriented mindset and a clear focus on feasibility.
Open to senior corporate roles in Market Access and Launch Strategy (freelance/contract).
Feel free to reach out if you'd like to discuss a project, partnership or corporate role.